W. J. Koopman, P. H. Willems, and J. A. Smeitink, Monogenic mitochondrial disorders, N. Engl. J. Med, vol.366, pp.1132-1141, 2012.

G. Pfeffer, K. Majamaa, D. M. Turnbull, D. Thorburn, and P. F. Chinnery, Treatment for mitochondrial disorders, Cochrane Database Syst Rev, vol.4, p.4426, 2012.

P. W. Stacpoole, The pharmacology of dichloroacetate, Metabolism, vol.38, pp.1124-1144, 1989.

J. Bastin, F. Aubey, A. Rotig, A. Munnich, and F. Djouadi, Activation of peroxisome proliferator--activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components, J. Clin. Endocrinol. Metab, vol.93, pp.1433-1441, 2008.

T. Wenz, X. Wang, M. Marini, and C. T. Moraes, A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations, J. Cell. Mol. Med, vol.15, pp.2317-2325, 2011.

C. Viscomi, E. Bottani, G. Civiletto, R. Cerutti, M. Moggio et al.,

C. Lamperti and M. Zeviani, In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC--1alpha Axis, Cell. Metab, vol.14, pp.80-90, 2011.

T. Wenz, F. Diaz, B. M. Spiegelman, and C. T. Moraes, Activation of the PPAR/PGC--. Metab, vol.8, pp.249-256, 2008.

R. C. Scarpulla, R. B. Vega, and D. P. Kelly, Transcriptional integration of mitochondrial biogenesis, Trends Endocrinol. Metab, vol.23, pp.459-466, 2012.

C. Handschin and B. M. Spiegelman, Peroxisome proliferator--activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism, Endocr. Rev, vol.27, pp.728-735, 2006.

P. J. Fernandez--marcos and J. Auwerx, Regulation of PGC--1alpha, a nodal regulator of mitochondrial biogenesis, Am. J. Clin. Nutr, vol.93, pp.884-890, 2011.

K. T. Howitz, K. J. Bitterman, H. Y. Cohen, D. W. Lamming, S. Lavu et al.,

P. Chung, A. Kisielewski, and L. L. Zhang, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, vol.425, pp.191-196, 2003.

S. J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams et al., Resveratrol ameliorates aging--related metabolic phenotypes by inhibiting cAMP phosphodiesterases, Cell, vol.148, pp.421-433, 2012.

N. L. Price, A. P. Gomes, A. J. Ling, F. V. Duarte, A. Martin--montalvo et al.,

L. Ye, G. Ramadori, and J. S. Teodoro, SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function, Cell. Metab, vol.15, pp.675-690, 2012.

B. D. Gehm, J. M. Mcandrews, P. Y. Chien, and J. L. Jameson, Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor, Proc. Natl. Acad. Sci. U S A, vol.94, pp.14138-14143, 1997.

J. Q. Chen, P. R. Cammarata, C. P. Baines, and J. D. Yager, Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications, Biochim. Biophys. Acta, vol.1793, pp.1540-1570, 2009.

L. J. Eichner and V. Giguere, Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks, Mitochondrion, vol.11, pp.544-552, 2011.

S. Arain, S. Weiss, E. Heinzle, G. T. John, C. Krause et al., Gas sensing in microplates with optodes: influence of oxygen exchange between sample, air, and plate material, 2005.

, Biotechnol. Bioeng, vol.90, pp.271-280

R. R. Deshpande, Y. Koch--kirsch, R. Maas, G. T. John, C. Krause et al., , 2005.

, Microplates with integrated oxygen sensors for kinetic cell respiration measurement and cytotoxicity testing in primary and secondary cell lines, Assay Drug Dev. Technol, vol.3, pp.299-307

F. Noor, J. Niklas, -. Muller, U. Vieira, and E. Heinzle, An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells, Toxicol. Appl. Pharmacol, vol.237, pp.221-231, 2009.

A. Heller, L. H. Fischer, O. S. Wolfbeis, and A. Goepferich, Long time monitoring of the respiratory activity of isolated mitochondria, Exp. Cell. Res, vol.318, pp.1667-1672, 2012.

B. H. Robinson, Lactic acidemia and mitochondrial disease, Mol. Genet. Metab, vol.89, pp.3-13, 2006.

D. Kang, S. H. Kim, and N. Hamasaki, Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions, Mitochondrion, vol.7, pp.39-44, 2007.

J. A. Baur, K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin et al., Resveratrol improves health and survival of mice on a high--calorie diet, Nature, vol.444, pp.337-342, 2006.

M. Lagouge, C. Argmann, Z. Gerhart--hines, H. Meziane, C. Lerin et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC--1alpha, Cell, vol.127, pp.1109-1122, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00188005

A. Csiszar, N. Labinskyy, J. T. Pinto, P. Ballabh, H. Zhang et al.,

R. Cabo, P. Pacher, and C. Zhang, Resveratrol induces mitochondrial biogenesis in endothelial cells, Am. J. Physiol. Heart Circ. Physiol, vol.297, pp.13-20, 2009.

J. M. Denu, Fortifying the link between SIRT1, resveratrol, and mitochondrial function, Cell Metab, vol.15, pp.566-567, 2012.

X. Hou, S. Xu, K. A. Maitland--toolan, K. Sato, B. Jiang et al., SIRT1 regulates hepatocyte lipid metabolism through activating AMP--activated protein kinase, J. Biol. Chem, vol.283, pp.20015-20026, 2008.

C. Canto, Z. Gerhart--hines, J. N. Feige, M. Lagouge, L. Noriega et al.,

P. Puigserver and J. Auwerx, AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity, Nature, vol.458, pp.1056-1060, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00383329

M. Bernier, R. K. Paul, A. Martin--montalvo, M. Scheibye--knudsen, S. Song et al.,

S. M. Armour, B. P. Hubbard, V. A. Bohr, and L. Wang, Negative regulation of STAT3 protein--mediated cellular respiration by SIRT1 protein, J. Biol. Chem, vol.286, pp.19270-19279, 2011.

F. Djouadi, F. Aubey, D. Schlemmer, and J. Bastin, Peroxisome Proliferator Activated Receptor {delta} (PPAR{delta}) Agonist But Not PPAR{alpha} Corrects Carnitine, 2005.

, Palmitoyl Transferase 2 Deficiency in Human Muscle Cells, J. Clin. Endocrinol. Metab, vol.90, pp.1791-1797

F. Djouadi, J. P. Bonnefont, L. Thuillier, V. Droin, N. Khadom et al., Correction of fatty acid oxidation in carnitine palmitoyl transferase 2--deficient cultured skin fibroblasts by bezafibrate, Pediatr. Res, vol.54, pp.446-451, 2003.

K. J. Menzies, K. Singh, A. Saleem, and D. A. Hood, Sirtuin 1--mediated effects of exercise and resveratrol on mitochondrial biogenesis, J. Biol. Chem, vol.288, pp.6968-6979, 2013.

J. L. Bowers, V. V. Tyulmenkov, S. C. Jernigan, and C. M. Klinge, Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta, Endocrinology, vol.141, pp.3657-3667, 2000.

C. Giordano, M. Montopoli, E. Perli, M. Orlandi, M. Fantin et al.,

L. Caparrotta, A. Martinuzzi, E. Ragazzi, and A. Ghelli, Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy, Brain, vol.134, pp.220-234, 2011.

T. E. Richardson, A. E. Yu, Y. Wen, S. H. Yang, and J. W. Simpkins, Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts, PLoS One, vol.7, p.34600, 2012.

E. L. Robb and J. A. Stuart, Resveratrol interacts with estrogen receptor--beta to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondrial superoxide dismutase. Free Radic, Biol. Med, vol.50, pp.821-831, 2011.

P. J. Willy, I. R. Murray, J. Qian, B. B. Busch, W. C. Stevens et al., Regulation of PPARgamma coactivator, vol.1, p.PGC, 2004.

, signaling by an estrogen--related receptor alpha (ERRalpha) ligand, Proc. Natl. Acad. Sci

. U-s-a, , vol.101, pp.8912-8917

V. K. Mootha, C. Handschin, D. Arlow, X. Xie, J. St-pierre et al.,

P. Puigserver and N. Patterson, Erralpha and Gabpa/b specify PGC--1alpha--dependent oxidative phosphorylation gene expression that is altered in diabetic muscle, Proc. Natl. Acad. Sci, 2004.

. U-s-a, , vol.101, pp.6570-6575

M. Suetsugi, L. Su, K. Karlsberg, Y. C. Yuan, and S. Chen, Flavone and isoflavone phytoestrogens are agonists of estrogen--related receptors, Mol. Cancer Res, vol.1, pp.981-991, 2003.

D. Liu, Z. Zhang, W. Gladwell, and C. T. Teng, Estrogen stimulates estrogen--related receptor alpha gene expression through conserved hormone response elements, 2003.

, Endocrinology, vol.144, pp.4894-4904

S. Timmers, E. Konings, L. Bilet, R. H. Houtkooper, T. Van-de-weijer et al.,

J. Hoeks, S. Van-der-krieken, D. Ryu, and S. Kersten, Calorie restriction--like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, Cell Metab, vol.14, pp.612-622, 2011.

J. Bastin, A. Lopes--costa, and F. Djouadi, Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation--deficient fibroblasts, Hum. Mol. Genet, vol.20, pp.2048-2057, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02894854

J. V. Passoneau and O. H. Lowry, Enzymatic Analysis: a practical guide, 1993.

A. Barrientos, In vivo and in organello assessment of OXPHOS activities, Methods, vol.26, pp.307-316, 2002.

P. Benit, D. Chretien, N. Kadhom, P. De-lonlay--debeney, V. Cormier--daire et al.,

S. Peudenier, P. Rustin, A. Munnich, and A. Rotig, Large--scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency, 2001.

, J. Hum. Genet, vol.68, pp.1344-1352

S. E. Calvo, E. J. Tucker, A. G. Compton, D. M. Kirby, G. Crawford et al.,

C. Guiducci, D. L. Bruno, and O. A. Goldberger, High--throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency, Nat. Genet, vol.42, pp.851-858, 2010.

L. C. Worgan, The role of nuclear--encoded subunit genes in mitochondrial complex I deficiency. Thesis, 2005.

P. Benit, R. Beugnot, D. Chretien, I. Giurgea, P. De-lonlay--debeney et al.,

M. Debrinski, S. Kerscher, P. Rustin, and A. Rotig, Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy, Hum. Mutat, vol.21, pp.582-586, 2003.

P. Benit, A. Slama, F. Cartault, I. Giurgea, D. Chretien et al.,

A. Rotig and P. Rustin, Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome, J. Med. Genet, vol.41, pp.14-17, 2004.

D. M. Kirby, R. Salemi, C. Sugiana, A. Ohtake, L. Parry et al.,

R. W. Taylor and H. H. Dahl, NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency, J. Clin. Invest, vol.114, pp.837-845, 2004.

D. J. Pagliarini, S. E. Calvo, B. Chang, S. A. Sheth, S. B. Vafai et al.,

C. Sugiana, A. Boneh, and W. K. Chen, A mitochondrial protein compendium elucidates complex I disease biology, Cell, vol.134, pp.112-123, 2008.

I. Valnot, J. C. Von-kleist--retzow, A. Barrientos, M. Gorbatyuk, J. W. Taanman et al.,

P. Rustin, A. Tzagoloff, A. Munnich, and A. Rotig, A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency, Hum. Mol. Genet, vol.9, pp.1245-1249, 2000.

V. Tiranti, K. Hoertnagel, R. Carrozzo, C. Galimberti, M. Munaro et al., Mutations of SURF--1 in Leigh disease associated with cytochrome c oxidase deficiency, Am. J. Hum. Genet, vol.63, pp.1609-1621, 1998.

V. Kleist--retzow, J. C. Yao, J. Taanman, J. W. Chantrel, K. Chretien et al., Mutations in SURF1 are not specifically associated with Leigh syndrome, J. Med. Genet, vol.38, pp.109-113, 2001.